New Therapeutics Pipeline Analysis for Supraventricular Tachycardia & More Diseases by GlobalData Published at

17 Aug 2012 • by Natalie Aster

LONDON – New market study "Supraventricular Tachycardia (SVT) Therapeutics - Pipeline Assessment and Market Forecasts to 2019" provided by GlobalData offers an insightful analytical review of the information on the global supraventricular tachycardia therapeutics market.

The report provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report offers valuable insights on the pipeline products within the global SVT therapeutics sector.

The report covers:

  • annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) SVT therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019; 
  • pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets; 
  • analysis of the current and future competition; 
  • insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications; 
  • key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the SVT therapeutics market; 
  • analysis of key recent licensing and partnership agreements in SVT therapeutics market.

Report Details:

Supraventricular Tachycardia (SVT) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Published: August, 2012
Pages: 88
Price: US$ 3.995,00

More New Therapeutics Pipeline Reviews by GlobalData Include:

More new market research reports by the publisher can be found at GlobalData page.


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970